Live In Unicorn Startup Jobs in Indiana (NOW HIRING)

IU Health and IU School of Medicine are seeking an academic medical oncologist to join the Genitourinary Oncology Program. This is a tenure track faculty position within the Department of Medicine, Division of Hematology/Oncology, at the IU School of Medicine.
This position is designed for a physician-scientist with focused expertise in GU malignancies + a strong commitment to translational, laboratory-based, + preclinical research. The successful candidate will join an established and active GU oncology program with a robust clinical trials portfolio and will help advance laboratory-driven discoveries that inform novel therapeutic strategies, biomarker development, correlative science, + investigator-initiated clinical trials.
The ideal candidate will have an independent laboratory program focused on GU cancer biology, drug development, biomarkers, mechanisms of resistance, tumor microenvironment, immuno-oncology, radiopharmaceuticals, antibody-drug conjugates, targeted therapies, or other areas of translational relevance to GU malignancies.
This role will include a disease-site-focused clinical practice in GU oncology, with at least 50% effort dedicated to translational research, laboratory investigation, + collaboration with clinical trial teams. will be supported with protected research time, a competitive startup package, laboratory space, access to NCI-designated cancer center resources, + robust clinical trial infrastructure.
Position Highlights
• Protected time for research, with clinical effort tailored to support the candidate's academic program
• Competitive startup support, including laboratory space and access to institutional research resources
• Access to clinical trial infrastructure, biospecimen resources, biostatistics, translational science collaborators, + disease-site research teams
• Opportunity to develop laboratory-driven concepts that support investigator-initiated, cooperative group, + industry-sponsored trials
• Engagement in multidisciplinary tumor boards, disease-site research meetings, education, + mentorship of trainees + junior faculty
Key Responsibilities
Lead a laboratory-based and/or preclinical research program focused on high-impact areas relevant to GU malignancies, including disease progression, therapeutic resistance, biomarker discovery, tumor biology, + novel drug development. Collaborate closely with GU clinical investigators to translate scientific discoveries into clinical trial concepts. Clinical responsibilities will include expert care of adults with GU cancers, with a clinical footprint aligned with the candidate's research goals. Pursue peer-reviewed funding (potential program project grants including SPOREs), publish in high-impact journals, mentor trainees + junior faculty, + participate in multidisciplinary + disease-site research programs.
Minimum Qualifications
• MD, MD/PhD, or equivalent degree
• BE/BC in Medical Oncology
• Ability to obtain an IN medical license
• Focused expertise in GU oncology
• Track record of scholarly productivity, including publications, presentations, grant funding
• Strong interest in integrating translational research with therapeutic clinical trials
• Commitment to multidisciplinary collaboration, mentorship, + academic program development
Preferred Qualifications
• Established laboratory program in GU oncology or a closely related field
• Track record of peer-reviewed funding or strong potential for sustained extramural funding
• Experience developing translational concepts that inform clinical trial design
• Experience collaborating with clinical trialists, basic scientists, pathology, precision genomic
Community Description
Indianapolis, Indiana , the 17th largest U.S. city, is a sophisticated city blending charm and culture with a wonderful balance of business and leisure. Residents of this dynamic city enjoy:

• Leading educational system and top-ranked universities, paired with a diverse population
• Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials
• Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States
• Top ranked international airport: " Best Airport in North America " twelve consecutive years
• Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country
• Historic neighborhoods with surrounding cultural districts and low cost of living
• Outdoor recreation includes golfing, boating and unique parks
• Home of the Colts ( NFL ), Fever ( WNBA ), Pacers ( NBA ), Indians ( MiLB ), Indianapolis 500 ( IndyCar ) and the nation's largest half marathon
• Close proximity to Chicago, St. Louis, Louisville, and Cincinnati

Healthcare System/Hospital Description
The Indiana University Melvin and Bren Simon Cancer Center is a patient care, research, and educational organization within the Indiana University School of Medicine , located on the school's main campus in Indianapolis.
Healthcare providers at IU Health Melvin and Bren Simon Cancer Center not only offer the highest level of patient care but many are engaged in research. As the only National Cancer Institute (NCI)-designated cancer center in the state of Indiana, IU Health Simon Cancer Center's researchers are recognized for meeting rigorous criteria for world-class, state-of-the-art programs in multidisciplinary cancer research. NCI-designated canc er centers put significant resources into developing research programs, faculty and facilities that will lead to better approaches to prevention, diagnosis and treatment of cancer.
In 2022, the IU Health Melvin and Bren Simon Cancer Center was admitted as a member of the National Comprehensive Cancer Network, an alliance of 32 leading cancer centers devoted to patient care, research and education.
The mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with patient-centered care, acceleration of promising science and collaborative educational programs. Research is vigorous, innovative and devoted to taking improved cancer care into the future. In all, more than 200 physicians, nurses, social workers, techologists and researchers are working to develop cures for cancer.
That teamwork leads to clinical breakthroughs, such as turning the cure rate of testicular cancer from 10 percent to nearly 95 percent today, among many others. The benefits to patients are clear: a wide range of innovative treatment options, expert teams of diverse professionals focused on their specific cancer type, and attention to all cancer care needs in one setting.